0001183740-18-000170.txt : 20181026 0001183740-18-000170.hdr.sgml : 20181026 20181026142136 ACCESSION NUMBER: 0001183740-18-000170 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181026 EFFECTIVENESS DATE: 20181026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Breathtec BioMedical, Inc. CENTRAL INDEX KEY: 0001642178 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324474 FILM NUMBER: 181141347 BUSINESS ADDRESS: STREET 1: SUITE 890 - 789 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1H2 BUSINESS PHONE: 604-646-1553 MAIL ADDRESS: STREET 1: SUITE 890 - 789 WEST PENDER STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1H2 FORMER COMPANY: FORMER CONFORMED NAME: Breathtec Biomedical, Inc. DATE OF NAME CHANGE: 20150512 D 1 primary_doc.xml X0708 D LIVE 0001642178 Breathtec BioMedical, Inc. Suite 915 - 700 West Pender Street VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 1G8 604-646-1553 BRITISH COLUMBIA, CANADA PBA Acquisitions Corp. Breathtec Biomedical, Inc. Corporation true 2015 Michael Sadhra Suite 915 - 700 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1G8 Executive Officer Director Christopher Moreau Suite 915 - 700 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1G8 Executive Officer Raj Attariwala Suite 915 - 700 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1G8 Director David Levine Suite 915 - 700 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1G8 Director Biotechnology Decline to Disclose 06b false 2018-10-19 true true true true true 140,000 post-consolidation common shares at deemed price of C$0.24 per share and 140,000 Replacement Warrants (see Item 10). true Pursuant to share exchange agreement among Issuer, Nash Pharmaceuticals Inc & Nash shareholders & warrantholders, Issuer acquired all shares of Nash and issued Replacement Warrants in consideration for cancellation of all Nash warrants previously issued 0 68373 25640 42733 Total Offering Amount equals to 140000 shares at C$0.24 per share and exercise price of the Warrants (140000 x C$0.40 per share). No guarantee that the Warrants expiring 10/4/2019 will be exercised. Based on exchange rate of US$1 = C$1.3104 on 10/19/2018. false 1 0 0 0 false Breathtec BioMedical, Inc. /s/ Christopher Moreau Christopher Moreau CEO 2018-10-24